












Orikeda Trashi
President at BioDelivera
Co-founder & President of BioDelivera (YC F26), building GCV™ for precise, programmable drug delivery to enable cures for every patient, across every disease. During her PhD, she spent five years researching drug delivery systems, developing the foundation for the Guided Chimeric Vehicle (GCV) platform.
Follow Orikeda
Alumnus of

The University of Texas at Dallas
Uniwersytet im. Adama Mickiewicza w Poznaniu
University of Tirana